HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of a CTL-directed epitope encoded by an intron of the putative tumor suppressor gene Testin of the common fragile site 7G region: a peptide vaccine candidate for HLA-B52+ and HLA-62+ cancer patients.

Abstract
Although cytotoxic T lymphocyte (CTL)-directed epitopes binding to human histocompatibility leukocyte antigen (HLA)-A molecules have been well characterized, those binding to HLA-B molecules have not, largely due to their large diversity. In this study we report a unique cancer antigen gene, tentatively named Testin-related gene (TRG), which encodes CTL-directed epitopes on the HLA-B52 molecules most frequently expressed in Asians. TRG is located in an intron of the putative tumor suppressor gene Testin in the common fragile site 7G region at 7q31.2. TRG mRNA was expressed in the majority of cancer cells and cancer tissue tested, whereas it was scarcely expressed in the majority of normal tissues, and only low-level expression of TRG was detected in the heart, liver, and pancreas. One TRG peptide had the ability to induce HLA-B52-restricted CTL cytotoxic to TRG+ tumor cells in peripheral blood mononuclear cells (PBMC) of epithelial cancer patients. This peptide also induced HLA-B62-restricted and tumor-reactive CTL in PBMC of cancer patients. Therefore, this TRG-derived peptide might be appropriate for use in peptide-based immunotherapy for relatively large numbers of cancer patients throughout the world, given that 34% of Japanese, 27% of Chinese, and 13% of Caucasians express either HLA-B52 or HLA-B62 molecules
AuthorsShinya Ohkouchi, Naoki Kawamoto, Makoto Koga, Fumi Sakanashi, Shigeki Shichijo, Yasuo Saijo, Toshihiro Nukiwa, Kyogo Itoh, Akira Yamada
JournalEuropean journal of immunology (Eur J Immunol) Vol. 33 Issue 11 Pg. 2964-73 (Nov 2003) ISSN: 0014-2980 [Print] Germany
PMID14579264 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cancer Vaccines
  • Cytoskeletal Proteins
  • Epitopes
  • HLA-B Antigens
  • HLA-B15 Antigen
  • HLA-B52 Antigen
  • HLA-Bw62
  • Homeodomain Proteins
  • LIM Domain Proteins
  • Proteins
  • RNA-Binding Proteins
  • TES protein, human
  • Tumor Suppressor Proteins
  • Vaccines, Subunit
Topics
  • Cancer Vaccines (immunology)
  • Cytoskeletal Proteins
  • Epitopes (immunology)
  • HLA-B Antigens (immunology)
  • HLA-B15 Antigen
  • HLA-B52 Antigen
  • Homeodomain Proteins
  • Humans
  • Introns (genetics, immunology)
  • LIM Domain Proteins
  • Neoplasms (immunology, therapy)
  • Proteins (genetics, immunology)
  • RNA-Binding Proteins
  • T-Lymphocytes, Cytotoxic (immunology)
  • Tumor Suppressor Proteins
  • Vaccines, Subunit (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: